Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Bandera

Showing results (21-30 of 240) with videos related to

Pageof 24
Sort By:
Neurogastroenterology and Motility|June 1, 2021
Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort studyDaniele Noviello, Andrea Costantino, Antonio Muscatello, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 16, 2024
New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD PropertiesAndrea Lombardi, Laura Alagna, Emanuele Palomba, et al.
Journal of Chemotherapy (Florence, Italy)|August 19, 2021
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samplesSara Baldelli, Matteo Cerea, Davide Mangioni, et al.
BMC Infectious Diseases|September 4, 2023
Non-tuberculous mycobacteria lung disease due to Mycobacterium chimaera in a 67-year-old man treated with immune checkpoint inhibitors for lung adenocarcinoma: infection due to dysregulated immunity?Cecilia Azzarà, Andrea Lombardi, Andrea Gramegna, et al.
Global Health & Medicine|December 17, 2020
The COVID-19 pandemic preparedness ... or lack thereof: from China to ItalySimone Villa, Andrea Lombardi, Davide Mangioni, et al.
BMC Infectious Diseases|March 8, 2014
Focal bone lesions in HIV-positive patient treated with tenofovirDavide Mangioni, Alessandra Bandera, Antonio Muscatello, et al.
Plos One|February 12, 2015
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trialAlessandro Soria, Daria Trabattoni, Nicola Squillace, et al.
IJID Regions|March 13, 2023
Retrospective analysis of bacteraemia due to extended-spectrum beta-lactamase-producing Enterobacterales: the challenge of healthcare-associated infectionsAnna Maria Peri, Davide Calabretta, Giorgio Bozzi, et al.
Plos One|December 3, 2010
Qualitative immune modulation by interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patientsFrancesca Sabbatini, Alessandra Bandera, Giulio Ferrario, et al.
Frontiers in Aging Neuroscience|August 21, 2019
HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression?Alessandra Bandera, Lucia Taramasso, Giorgio Bozzi, et al.
Pageof 24

Showing results (21-30 of 240) with videos related to

Sort By:
Pageof 24
Neurogastroenterology and Motility|June 1, 2021
Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort studyDaniele Noviello, Andrea Costantino, Antonio Muscatello, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 16, 2024
New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD PropertiesAndrea Lombardi, Laura Alagna, Emanuele Palomba, et al.
Journal of Chemotherapy (Florence, Italy)|August 19, 2021
Fosfomycin therapeutic drug monitoring in real-life: development and validation of a LC-MS/MS method on plasma samplesSara Baldelli, Matteo Cerea, Davide Mangioni, et al.
BMC Infectious Diseases|September 4, 2023
Non-tuberculous mycobacteria lung disease due to Mycobacterium chimaera in a 67-year-old man treated with immune checkpoint inhibitors for lung adenocarcinoma: infection due to dysregulated immunity?Cecilia Azzarà, Andrea Lombardi, Andrea Gramegna, et al.
Global Health & Medicine|December 17, 2020
The COVID-19 pandemic preparedness ... or lack thereof: from China to ItalySimone Villa, Andrea Lombardi, Davide Mangioni, et al.
BMC Infectious Diseases|March 8, 2014
Focal bone lesions in HIV-positive patient treated with tenofovirDavide Mangioni, Alessandra Bandera, Antonio Muscatello, et al.
Plos One|February 12, 2015
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trialAlessandro Soria, Daria Trabattoni, Nicola Squillace, et al.
IJID Regions|March 13, 2023
Retrospective analysis of bacteraemia due to extended-spectrum beta-lactamase-producing Enterobacterales: the challenge of healthcare-associated infectionsAnna Maria Peri, Davide Calabretta, Giorgio Bozzi, et al.
Plos One|December 3, 2010
Qualitative immune modulation by interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patientsFrancesca Sabbatini, Alessandra Bandera, Giulio Ferrario, et al.
Frontiers in Aging Neuroscience|August 21, 2019
HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression?Alessandra Bandera, Lucia Taramasso, Giorgio Bozzi, et al.
Pageof 24